BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30707314)

  • 1. Impact of levosimendan on weaning from peripheral venoarterial extracorporeal membrane oxygenation in intensive care unit.
    Vally S; Ferdynus C; Persichini R; Bouchet B; Braunberger E; Lo Pinto H; Martinet O; Vandroux D; Aujoulat T; Allyn J; Allou N
    Ann Intensive Care; 2019 Feb; 9(1):24. PubMed ID: 30707314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Levosimendan Administration Improved Weaning Success Rate in Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock.
    Chen YW; Lee WC; Wu PJ; Fang HY; Fang YN; Chen HC; Tong MS; Sung PH; Lee CH; Chung WJ
    Front Cardiovasc Med; 2022; 9():912321. PubMed ID: 35845047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis.
    Guilherme E; Jacquet-Lagrèze M; Pozzi M; Achana F; Armoiry X; Fellahi JL
    Crit Care; 2020 Jul; 24(1):442. PubMed ID: 32677985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levosimendan's effect on venoarterial extracorporeal membrane oxygenation weaning.
    Hau M; Fong KM; Au SY
    Int J Artif Organs; 2022 Jun; 45(6):571-579. PubMed ID: 35570732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term effects of levosimendan use for venoarterial extracorporeal membrane oxygenation: A systematic review and meta-analysis.
    Yang B; Zhao T; Guo B; Li Y
    Perfusion; 2023 Mar; 38(2):305-312. PubMed ID: 34689640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of levosimendan on the outcome of veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis.
    Liu Y; Zhang L; Yao Y; Li Y; Qin W; Li Y; Xue W; Li P; Chen Y; Chen X; Guo H
    Clin Res Cardiol; 2024 Apr; 113(4):509-521. PubMed ID: 37217802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levosimendan in venoarterial ECMO weaning. Rational and design of a randomized double blind multicentre trial.
    Ellouze O; Soudry Faure A; Radhouani M; Abou-Arab O; Besnier E; Moussa M; Cransac A; Ksiazek E; Fischer MO; Mertes PM; Bouhemad B; Guinot PG
    ESC Heart Fail; 2021 Aug; 8(4):3339-3347. PubMed ID: 34145993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effectiveness of Levosimendan on Veno-Arterial Extracorporeal Membrane Oxygenation Management and Outcome: A Systematic Review and Meta-Analysis.
    Kaddoura R; Omar AS; Ibrahim MIM; Alkhulaifi A; Lorusso R; Elsherbini H; Soliman O; Caliskan K
    J Cardiothorac Vasc Anesth; 2021 Aug; 35(8):2483-2495. PubMed ID: 33583718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levosimendan in veno-arterial extracorporeal membrane oxygenator supported patients: Impact on the success of weaning and survival.
    Alonso-Fernandez-Gatta M; Merchan-Gomez S; Gonzalez-Cebrian M; Diego-Nieto A; Alzola E; Toranzo-Nieto I; Barrio A; Martin-Herrero F; Sanchez PL
    Artif Organs; 2021 Jul; 45(7):717-725. PubMed ID: 33377185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of levosimendan in weaning children requiring veno-arterial extracorporeal membrane oxygenation after cardiac surgery.
    Pan KC; Shankar S; Millar J; Chiletti R; Butt W; d'Udekem Y; Namachivayam SP
    Eur J Cardiothorac Surg; 2021 Jan; 59(1):262-268. PubMed ID: 32910173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levosimendan in patients undergoing extracorporeal membrane oxygenation after cardiac surgery: an emulated target trial using observational data.
    Massol J; Simon-Tillaux N; Tohme J; Hariri G; Dureau P; Duceau B; Belin L; Hajage D; De Rycke Y; Charfeddine A; Lebreton G; Combes A; Bouglé A
    Crit Care; 2023 Feb; 27(1):51. PubMed ID: 36750852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levosimendan may improve weaning outcomes in venoarterial ECMO patients.
    Affronti A; di Bella I; Carino D; Ragni T
    ASAIO J; 2013; 59(6):554-7. PubMed ID: 24172260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of levosimendan on survival and weaning from ECMO after extracorporeal cardiopulmonary resuscitation.
    Gaisendrees C; Schlachtenberger G; Gerfer S; Krasivskyi I; Djordjevic I; Sabashnikov A; Kosmopoulos M; Jaeger D; Luehr M; Kuhn E; Deppe AC; Wahlers T
    Artif Organs; 2023 Aug; 47(8):1351-1360. PubMed ID: 37032531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanical support with venoarterial extracorporeal membrane oxygenation (ECMO-VA): Short-term and long-term prognosis after a successful weaning.
    García-Gigorro R; Renes-Carreño E; Pérez-Vela JL; Marín-Mateos H; Gutiérrez J; Corrés-Peiretti MA; Delgado JF; Pérez-de la Sota E; Cortina-Romero JM; Montejo-González JC
    Med Intensiva; 2017 Dec; 41(9):513-522. PubMed ID: 28259366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of levosimendan on weaning and survival in adult cardiogenic shock patients with veno-arterial extracorporeal membrane oxygenation: systematic review and meta-analysis.
    Burgos LM; Seoane L; Furmento JF; Costabel JP; Diez M; Vrancic M; Aissaoui N; Benzadón MN; Navia D
    Perfusion; 2020 Sep; 35(6):484-491. PubMed ID: 32449494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echocardiographic Predictors of Successful Extracorporeal Membrane Oxygenation Weaning After Refractory Cardiogenic Shock.
    Kim D; Jang WJ; Park TK; Cho YH; Choi JO; Jeon ES; Yang JH
    J Am Soc Echocardiogr; 2021 Apr; 34(4):414-422.e4. PubMed ID: 33321165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect evaluation of bedside ultrasound monitoring of left ventricular functional parameters combined with clinical indicators on veno-arterial extracorporeal membrane oxygenation].
    Yi R; Guo J; Zhou Q; Song H; Zhou Y; Jiang N; Yao X; Guo R
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Mar; 33(3):329-333. PubMed ID: 33834975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-hospital mortality and successful weaning from venoarterial extracorporeal membrane oxygenation: analysis of 5,263 patients using a national inpatient database in Japan.
    Aso S; Matsui H; Fushimi K; Yasunaga H
    Crit Care; 2016 Apr; 20():80. PubMed ID: 27044572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of levosimendan to wean patients from VA-ECMO: a systematic review and meta-analysis.
    Bertini P; Paternoster G; Landoni G; Falcone M; Nocci M; Costanzo D; Brizzi G; Romani M; Esposito A; Guarracino F
    Minerva Cardiol Angiol; 2023 Oct; 71(5):564-574. PubMed ID: 35687316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of levosimendan on survival in patients undergoing extracorporeal membrane oxygenation after cardiovascular surgery.
    Distelmaier K; Roth C; Schrutka L; Binder C; Steinlechner B; Heinz G; Lang IM; Maurer G; Koinig H; Niessner A; Hülsmann M; Speidl W; Goliasch G
    Br J Anaesth; 2016 Jul; 117(1):52-8. PubMed ID: 27317704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.